Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
暂无分享,去创建一个
M. J. van de Vijver | S. Eschrich | M. Bollet | J. Torres-Roca | N. Servant | E. Harris | W. Fulp | A. Naghavi | J. Caudell
[1] G. Semenza,et al. Hypoxia-inducible factor 1 and breast cancer metastasis , 2015, Journal of Zhejiang University-SCIENCE B.
[2] S. Eschrich,et al. A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer , 2014, medRxiv.
[3] T. Strom,et al. Radiosensensitivity Index Shows Promise for Predicting Outcomes With Adjuvant Radiation in Resected Pancreatic Cancer Patients , 2014 .
[4] S. Eschrich,et al. Radiosensitivity Molecular Signature Is Predictive of Overall Survival in Glioblastoma , 2014 .
[5] S. Eschrich,et al. A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer , 2014 .
[6] Jay R. Harris,et al. Diseases of the Breast , 2014 .
[7] M. Clemons,et al. Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research , 2013, Breast Cancer Research and Treatment.
[8] Ana Lluch,et al. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. , 2012, Cancer treatment reviews.
[9] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[10] M. Kerin,et al. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.
[11] Yudi Pawitan,et al. Validation of a Radiosensitivity Molecular Signature in Breast Cancer , 2012, Clinical Cancer Research.
[12] Emmanuel Barillot,et al. Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women , 2012, Clinical Cancer Research.
[13] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.
[14] Barbara L. Smith,et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] W. Woodward,et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation , 2011, Annals of Surgical Oncology.
[16] J. Deschênes,et al. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] T. Nielsen,et al. Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] David Boulware,et al. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.
[19] Steven Eschrich,et al. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. , 2009, International journal of radiation oncology, biology, physics.
[20] G. Clark,et al. Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib , 2008, Molecular oncology.
[21] Laurence Collette,et al. Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial , 2007 .
[22] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[23] L Collette,et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? , 2003, European journal of cancer.
[24] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[25] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[26] J. Gunther,et al. Impact of Pretreatment Combined 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer , 2016 .
[27] M. Morrow,et al. Comprar Harris. Enfermedades de la Mama. 4Ed | C. K. Osborne | 9878496921627 | Lippincott Williams & Wilkins , 2010 .
[28] Jong-Hyeon Jeong,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.